The Federal Trade Commission's extended review of Alcon's proposed $430 million acquisition of Lensar Inc. highlights growing regulatory attention on medical technology consolidation. While the...
As global mining giants recalibrate portfolios amid shifting commodity demands, Dundee Precious Metals' (TSX:DPM) potential acquisition of Adriatic Metals (LSE:ADT1) emerges as a defining...
An Illinois appellate panel affirmed the dismissal of a shareholder class action against AbbVie Inc. on May 21, 2025, resolving allegations that the biopharmaceutical giant issued unregistered...
In a strategic move to strengthen its neurology pipeline, Sanofi announced on May 21, 2025, its definitive agreement to acquire Vigil Neuroscience for up to $600 million. The transaction centers on...
Global private equity leader Blackstone has emerged as the frontrunner to acquire healthcare revenue cycle management (RCM) specialist AGS Health from EQT Private Capital Asia in a deal valuing the...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand In a landmark decision reflecting converging trends in healthcare innovation and digital asset strategy, KindlyMD shareholders...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand Private equity firm Cinven has entered exclusive negotiations to acquire French clinical nutrition specialist Nutrisens from...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand In a landmark move reshaping the rare disease therapeutics landscape, BioMarin Pharmaceutical announced its $270 million...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand In a dramatic twist to one of 2025's most consequential REIT mergers, Primary Health Properties (LSE: PHP) has launched a £1.68...
Click here for seasoned global CorpDev/ M&A/ PE expertise on demand Deal Snapshot: 23andMe Acquisition AcquirerRegeneron Pharmaceuticals Target23andMe (excl. Lemonaid Health) Price$256M (92% below...
